145 related articles for article (PubMed ID: 8786206)
1. p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study.
Schammel DP; Bocklage T
Int J Gynecol Pathol; 1996 Apr; 15(2):158-66. PubMed ID: 8786206
[TBL] [Abstract][Full Text] [Related]
2. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy.
Lage JM; Mark SD; Roberts DJ; Goldstein DP; Bernstein MR; Berkowitz RS
Obstet Gynecol; 1992 Mar; 79(3):403-10. PubMed ID: 1371185
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Ki-67 (MIB-1) in placentas with hydropic change and partial and complete hydatidiform mole.
Cheville JC; Robinson R; Benda JA
Pediatr Pathol Lab Med; 1996; 16(1):41-50. PubMed ID: 8963630
[TBL] [Abstract][Full Text] [Related]
4. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses.
Merchant SH; Amin MB; Viswanatha DS; Malhotra RK; Moehlenkamp C; Joste NE
Hum Pathol; 2005 Feb; 36(2):180-6. PubMed ID: 15754295
[TBL] [Abstract][Full Text] [Related]
5. p53 expression in placentas with hydropic change and hydatidiform moles.
Cheville JC; Robinson RA; Benda JA
Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry of molar and non-molar placentas with special reference to their differential diagnosis.
Fukunaga M; Miyazawa Y; Sugishita M; Ushigome S
Acta Pathol Jpn; 1993 Nov; 43(11):683-9. PubMed ID: 7508673
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
[TBL] [Abstract][Full Text] [Related]
8. Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry.
Crisp H; Burton JL; Stewart R; Wells M
Histopathology; 2003 Oct; 43(4):363-73. PubMed ID: 14511255
[TBL] [Abstract][Full Text] [Related]
9. Hydatidiform moles. Application of flow cytometry in diagnosis.
Lage JM; Driscoll SG; Yavner DL; Olivier AP; Mark SD; Weinberg DS
Am J Clin Pathol; 1988 May; 89(5):596-600. PubMed ID: 3358367
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic testing from paraffin-embedded tissue distinguishes nonmolar hydropic abortion from hydatidiform mole.
Bell KA; Van Deerlin V; Addya K; Clevenger CV; Van Deerlin PG; Leonard DG
Mol Diagn; 1999 Mar; 4(1):11-9. PubMed ID: 10229770
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy of hydatidiform moles and nonmolar conceptuses: a study using flow and tissue section image cytometry.
Berezowsky J; Zbieranowski I; Demers J; Murray D
Mod Pathol; 1995 Sep; 8(7):775-81. PubMed ID: 8539237
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of c-erbB-2, Bcl-2, p53, p21
Missaoui N; Landolsi H; Mestiri S; Essakly A; Abdessayed N; Hmissa S; Mokni M; Yacoubi MT
Pathol Res Pract; 2019 Mar; 215(3):446-452. PubMed ID: 30558966
[TBL] [Abstract][Full Text] [Related]
13. Molar gestations and hydropic abortions differentiated by p57 immunostaining.
Romaguera RL; Rodriguez MM; Bruce JH; Zuluaga T; Viciana A; Penalver MA; Mehrdad N
Fetal Pediatr Pathol; 2004; 23(2-3):181-90. PubMed ID: 15768863
[TBL] [Abstract][Full Text] [Related]
14. Use of proliferation cell nuclear antigen immunoreactivity for distinguishing hydropic abortions from partial hydatidiform moles.
Suresh UR; Hale RJ; Fox H; Buckley CH
J Clin Pathol; 1993 Jan; 46(1):48-50. PubMed ID: 8094402
[TBL] [Abstract][Full Text] [Related]
15. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions.
Paradinas FJ; Browne P; Fisher RA; Foskett M; Bagshawe KD; Newlands E
Histopathology; 1996 Feb; 28(2):101-10. PubMed ID: 8834517
[TBL] [Abstract][Full Text] [Related]
16. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
17. p53 and Bcl-2 oncoprotein expression in placentas with hydropic changes and partial and complete moles.
Al-Bozom IA
APMIS; 2000 Nov; 108(11):756-60. PubMed ID: 11211969
[TBL] [Abstract][Full Text] [Related]
18. Expressions of p53, proliferating cell nuclear antigen, and Ki-67 in gestational trophoblastic diseases.
Uzunlar AK; Yilmaz F; Bayhan G; Akkuş Z
Eur J Gynaecol Oncol; 2002; 23(1):79-83. PubMed ID: 11876401
[TBL] [Abstract][Full Text] [Related]
19. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
20. Proliferative activity in placentas with hydropic change and hydatidiform mole as detected by Ki-67 and proliferating cell nuclear antigen immunostaining.
Ostrzega N; Phillipson J; Liu P
Am J Clin Pathol; 1998 Dec; 110(6):776-81. PubMed ID: 9844590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
